Abstract
The results of these pooled data do not support the notion that postmenopausal hormone therapy prevents cardiovascular events.
Keywords
MedicineHormone therapyOdds ratioInternal medicinePlaceboIncidence (geometry)CancerConfidence intervalClinical trialAdverse effectOncologyBreast cancerPathology
Affiliated Institutions
Related Publications
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
▪ Abstract Multiple observational studies suggest a marked reduction in risk of coronary heart disease (CHD) associated with postmenopausal estrogen use. A new meta-analysis pre...
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women. All-cause mortality ...
Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
During an average follow-up of 4.1 years, treatment with oral conjugated equine estrogen plus medroxyprogesterone acetate did not reduce the overall rate of CHD events in postme...
The Effects of Estrogen and Selective Estrogen Receptor Modulators on Cardiovascular Risk Factors
A bstract : Raloxifene, a selective estrogen receptor modulator, favorably alters several markers of cardiovascular risk in healthy postmenopausal women. While many of its effec...
Multiple risk factor interventions for primary prevention of coronary heart disease
Interventions using counselling and education aimed at behaviour change do not reduce total or CHD mortality or clinical events in general populations but may be effective in re...
Publication Info
- Year
- 1997
- Type
- review
- Volume
- 315
- Issue
- 7101
- Pages
- 149-153
- Citations
- 254
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
254
OpenAlex
Cite This
Elina Hemminki,
Klim McPherson
(1997).
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials.
BMJ
, 315
(7101)
, 149-153.
https://doi.org/10.1136/bmj.315.7101.149
Identifiers
- DOI
- 10.1136/bmj.315.7101.149